United States· US:52015-080_21c95e9f-0a3d-4fb8-90b5-934bad817d00
Dificid
A fidaxomicin product containing fidaxomicin, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Fidaxomicin is registered in 16 of 19 countries.
Countries holding a registration under ATC A07AA12 (fidaxomicin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Fidaxomicin · ATC A07AA12
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fidaxomicin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fidaxomicin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$179.87
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FIDAXOMICIN
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- A07AA12
- ATC class
- Fidaxomicin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1152015080011 BOTTLE in 1 CARTON (52015-080-01) / 20 TABLET, FILM COATED in 1 BOTTLE
- ndc1152015-080-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
101 interactions on record for fidaxomicin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fidaxomicin · interactions on record
101 records
- 3 severe
- 24 moderate
- 74 minor
Most severe, free to view
- BerotralstatB06AC06severe
- VenetoclaxL01XX52severe
- RelugolixL02BX04severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fidaxomicin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDIFICLIR 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULATillotts Pharma Gmbh
- CzechiaDIFICLIRTillotts Pharma GmbH, Rheinfelden
- SwedenDIFICLIR 200 mg Filmdragerad tablettTillotts Pharma GmbH
- BelgiumDificlir 200 mgTillotts Pharma
- IcelandDificlirTillotts Pharma GmbH
- NetherlandsDificlir, 200mg, filmomhulde tablettenTillotts Pharma GmbH
- NorwayDificlirTillotts Pharma GmbH
- PolandDificlirTillotts Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- France · Fidaxomicine Sun
- United Kingdom (Northern Ireland) · Fidaxomicin Tillotts 200 Mg, Fidaxomicin Tillotts 40 Mg/Ml
- Iceland · Dificlir
- Liechtenstein · Dificlir, Dificlir 200 Mg
- Norway · Dificlir, Dificlir 200 Mg
- Sweden · Fidaxomicin Sun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a973d73-8ce2-40a7-b264-dbe99680fc4f GET /v1/drugs/1a973d73-8ce2-40a7-b264-dbe99680fc4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "FIDAXOMICIN",
"productndc": "52015-080",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA201699",
"marketing_category": "NDA"
}See everything about fidaxomicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.